Literature DB >> 26209626

The TNF Family Molecules LIGHT and Lymphotoxin αβ Induce a Distinct Steroid-Resistant Inflammatory Phenotype in Human Lung Epithelial Cells.

Ricardo da Silva Antunes1, Lisa Madge2, Pejman Soroosh3, Joel Tocker2, Michael Croft4.   

Abstract

Lung epithelial cells are considered important sources of inflammatory molecules and extracellular matrix proteins that contribute to diseases such as asthma. Understanding the factors that stimulate epithelial cells may lead to new insights into controlling lung inflammation. This study sought to investigate the responsiveness of human lung epithelial cells to the TNF family molecules LIGHT and lymphotoxin αβ (LTαβ). Bronchial and alveolar epithelial cell lines, and primary human bronchial epithelial cells, were stimulated with LIGHT and LTαβ, and expression of inflammatory cytokines and chemokines and markers of epithelial-mesenchymal transition and fibrosis/remodeling was measured. LTβ receptor, the receptor shared by LIGHT and LTαβ, was constitutively expressed on all epithelial cells. Correspondingly, LIGHT and LTαβ strongly induced a limited but highly distinct set of inflammatory genes in all epithelial cells tested, namely the adhesion molecules ICAM-1 and VCAM-1; the chemokines CCL5, CCL20, CXCL1, CXCL3, CXCL5, and CXCL11; the cytokines IL-6, activin A and GM-CSF; and metalloproteinases matrix metalloproteinase-9 and a disintegrin and metalloproteinase domain-8. Importantly, induction of the majority of these inflammatory molecules was insensitive to the suppressive effects of the corticosteroid budesonide. LIGHT and LTαβ also moderately downregulated E-cadherin, a protein associated with maintaining epithelial integrity, but did not significantly drive production of extracellular matrix proteins or α-smooth muscle actin. Thus, LIGHT and LTαβ induce a distinct steroid-resistant inflammatory signature in airway epithelial cells via constitutively expressed LTβ receptor. These findings support our prior murine studies that suggested the receptors for LIGHT and LTαβ contribute to development of lung inflammation characteristic of asthma and idiopathic pulmonary fibrosis.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26209626      PMCID: PMC4546856          DOI: 10.4049/jimmunol.1500356

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  The role of rhinovirus in asthma exacerbations.

Authors:  Samuel L Friedlander; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2005-08       Impact factor: 10.793

2.  Expression of ADAMs and their inhibitors in sputum from patients with asthma.

Authors:  Geneviève Paulissen; Natacha Rocks; Florence Quesada-Calvo; Philippe Gosset; Jean-Michel Foidart; Agnès Noel; Renaud Louis; Didier D Cataldo
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

Review 3.  Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Authors:  Carl F Ware
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

4.  Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma.

Authors:  Lena Uller; Marina Leino; Nicole Bedke; David Sammut; Ben Green; Laurie Lau; Peter H Howarth; Stephen T Holgate; Donna E Davies
Journal:  Thorax       Date:  2010-07       Impact factor: 9.139

5.  Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma.

Authors:  Kyung Sun Lee; Kyung Hoon Min; So Ri Kim; Seoung Ju Park; Hee Sun Park; Gong Yong Jin; Yong Chul Lee
Journal:  Am J Respir Crit Care Med       Date:  2006-04-27       Impact factor: 21.405

6.  Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics.

Authors:  G Mautino; N Oliver; P Chanez; J Bousquet; F Capony
Journal:  Am J Respir Cell Mol Biol       Date:  1997-11       Impact factor: 6.914

Review 7.  Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation.

Authors:  Steve N Georas; Fariba Rezaee
Journal:  J Allergy Clin Immunol       Date:  2014-07-29       Impact factor: 10.793

8.  Sputum ADAM8 expression is increased in severe asthma and COPD.

Authors:  K M Oreo; P G Gibson; J L Simpson; L G Wood; V M McDonald; K J Baines
Journal:  Clin Exp Allergy       Date:  2014-03       Impact factor: 5.018

Review 9.  Genetic and genomic approaches to asthma: new insights for the origins.

Authors:  Youming Zhang; Miriam F Moffatt; William O C Cookson
Journal:  Curr Opin Pulm Med       Date:  2012-01       Impact factor: 3.155

10.  An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.

Authors:  Stephanie Traub; Alexandra Nikonova; Alan Carruthers; Rebecca Dunmore; Katherine A Vousden; Leila Gogsadze; Weidong Hao; Qing Zhu; Katie Bernard; Jie Zhu; Michael Dymond; Gary R McLean; Ross P Walton; Nicholas Glanville; Alison Humbles; Musa Khaitov; Ted Wells; Roland Kolbeck; Andrew J Leishman; Matthew A Sleeman; Nathan W Bartlett; Sebastian L Johnston
Journal:  PLoS Pathog       Date:  2013-08-01       Impact factor: 6.823

View more
  11 in total

1.  Tumor necrosis factor family member LIGHT acts with IL-1β and TGF-β to promote airway remodeling during rhinovirus infection.

Authors:  A K Mehta; T Doherty; D Broide; M Croft
Journal:  Allergy       Date:  2018-03-01       Impact factor: 13.146

Review 2.  Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.

Authors:  Michael Croft; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

Review 3.  Ezrin Orchestrates Signal Transduction in Airway Cells.

Authors:  Lei-Miao Yin; Ting-Ting Duan; Luis Ulloa; Yong-Qing Yang
Journal:  Rev Physiol Biochem Pharmacol       Date:  2018       Impact factor: 5.545

4.  Realigning the LIGHT signaling network to control dysregulated inflammation.

Authors:  Carl F Ware; Michael Croft; Garry A Neil
Journal:  J Exp Med       Date:  2022-05-23       Impact factor: 17.579

Review 5.  Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense.

Authors:  Ekaterina P Koroleva; Yang-Xin Fu; Alexei V Tumanov
Journal:  Cytokine       Date:  2016-09-09       Impact factor: 3.861

6.  The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF Superfamily member 14).

Authors:  Rana Herro; Michael Croft
Journal:  Pharmacol Res       Date:  2015-12-31       Impact factor: 7.658

7.  Cutting Edge: The RNA-Binding Protein Ewing Sarcoma Is a Novel Modulator of Lymphotoxin β Receptor Signaling.

Authors:  Richard Virgen-Slane; Ricardo G Correa; Parham Ramezani-Rad; Seth Steen-Fuentes; Thiago Detanico; Michael J DiCandido; Jun Li; Carl F Ware
Journal:  J Immunol       Date:  2020-01-22       Impact factor: 5.422

8.  Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series).

Authors:  Jonathan A Kropski; Bradley W Richmond; Christa F Gaskill; Robert F Foronjy; Susan M Majka
Journal:  Pulm Circ       Date:  2017-10-17       Impact factor: 3.017

9.  A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy.

Authors:  Ricardo da Silva Antunes; Ferran Soldevila; Mikhail Pomaznoy; Mariana Babor; Jason Bennett; Yuan Tian; Natalie Khalil; Yu Qian; Aishwarya Mandava; Richard H Scheuermann; Mario Cortese; Bali Pulendran; Christopher D Petro; Adrienne P Gilkes; Lisa A Purcell; Alessandro Sette; Bjoern Peters
Journal:  JCI Insight       Date:  2021-04-08

10.  TNFSF14 (LIGHT) Exhibits Inflammatory Activities in Lung Fibroblasts Complementary to IL-13 and TGF-β.

Authors:  Ricardo da Silva Antunes; Amit K Mehta; Lisa Madge; Joel Tocker; Michael Croft
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.